L&C BIO
엘앤씨바이오KRX: 290650· Fiscal year 2025· lncbio.co.kr ↗
Average salary
$34.8K
₩46.3M
▼ 5.7% vs 2024
Employees
155
▲ 14.8% vs 2024
Average tenure
3.5 yrs
Estimated take-home of this pay:$2.5K / monthCalculate →
Workplace
Women's pay (men = 100)66
Women among staff41.9%
Contract staff6.5%
Recent official filings
- 2026-11-16Investor relations (IR) event
- 2026-11-13Quarterly report (2026.09)
- 2026-11-09Preliminary earnings
- 2026-11-09Preliminary earnings (consolidated)
- 2026-10-23MajorBonus share issue
- 2026-10-16MajorShare issuance result
Quick read
- Average pay is 24% below the median of the companies we track.
- Average pay fell 5.7% from 2024.
- Headcount grew by 20 (14.8%) from 2024.
- Ranks #208 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 18.7% year over year.
- Revenue has grown two years in a row.
- Operating margin was 5.2% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $412.9K
- Net profit per employee
- -$667.9K
- Operating margin
- 5.2%
- Net margin
- -161.7%
- ROE
- -66.3%
- Debt-to-equity
- 119.0%
- Equity ratio
- 45.7%
- Dividend per share
- $0
- Dividend yield (as disclosed)
- 0.1%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.